ArticleTheranostics2020

Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.

Yuning Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.